Wells Fargo & Company Adicet Bio, Inc. Transaction History

Wells Fargo & Company

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.76 - $3.45 $16,758 - $32,850	9,522 Added 101.52%	18,901 $44,000
Q4 2023 Feb 09, 2024	BUY	$1.11 - $1.89 $2,053 - $3,496	1,850 Added 24.57%	9,379 $17,000
Q3 2023 Nov 13, 2023	SELL	$1.37 - $3.4 $5,555 - $13,787	-4,055 Reduced 35.01%	7,529 $10,000
Q2 2023 Aug 15, 2023	BUY	$2.13 - $7.13 $13,176 - $44,106	6,186 Added 114.6%	11,584 $28,000
Q1 2023 May 12, 2023	BUY	$5.52 - $9.23 $29,796 - $49,823	5,398 New	5,398 $31,000
Q3 2022 Nov 14, 2022	BUY	$13.43 - $18.74 $8,460 - $11,806	630 Added 215.02%	923 $13,000
Q2 2022 Aug 12, 2022	SELL	$10.26 - $20.81 $13,697 - $27,781	-1,335 Reduced 82.0%	293 $4,000
Q1 2022 May 16, 2022	SELL	$11.53 - $19.97 $81,378 - $140,948	-7,058 Reduced 81.26%	1,628 $33,000
Q4 2021 Feb 14, 2022	SELL	$7.37 - $17.49 $30,298 - $71,901	-4,111 Reduced 32.12%	8,686 $152,000
Q3 2021 Nov 15, 2021	BUY	$6.29 - $9.93 $80,486 - $127,064	12,796 Added 1279600.0%	12,797 $100,000
Q1 2021 May 13, 2021	SELL	$12.12 - $17.17 $112,570 - $159,474	-9,288 Reduced 99.99%	1 $0
Q4 2020 Feb 09, 2021	BUY	$10.36 - $14.77 $96,223 - $137,183	9,288 Added 928800.0%	9,289 $130,000
Q3 2020 Nov 05, 2020	BUY	$10.18 - $21.4 $10 - $21	1 New	1 $0

66.3M

4.3K

36.3K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $57.6M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.